[{"id":6210,"regimens":[{"id":11873,"duration":{"id":5871,"approximate_duration":null,"dates_unknown":false},"drug":{"id":5901,"name":"Amoxicillin","url":"cure-api2.ncats.io/v1/drugs/5901","rxNorm_id":null,"notes":null},"use_drug":[{"id":8998,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11873},{"id":8999,"answer":"In a novel combination with another drug","answer_other":"","regimen":11873}],"created":"2020-10-07T19:00:35.013812Z","updated":"2020-11-05T18:02:11.831600Z","dose":"500mg","frequency":"q3d","route":"Orally","severity":"Inpatient","severity_detail":"","comments":null,"report":6210},{"id":11874,"duration":{"id":5872,"approximate_duration":null,"dates_unknown":false},"drug":{"id":9560,"name":"Paracetamol","url":"cure-api2.ncats.io/v1/drugs/9560","rxNorm_id":null,"notes":null},"use_drug":[{"id":9000,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11874},{"id":9001,"answer":"In a novel combination with another drug","answer_other":"","regimen":11874}],"created":"2020-10-07T19:00:35.021411Z","updated":"2020-11-05T18:02:11.838296Z","dose":"1g","frequency":"q4d","route":"Orally","severity":"Inpatient","severity_detail":"","comments":null,"report":6210}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8152,"answer":"Clinical assessment","answer_other":"","report":6210}],"how_diagnosis":[{"id":13877,"answer":"Clinical assessment","answer_other":"","report":6210},{"id":13878,"answer":"Imaging","answer_other":"","report":6210},{"id":13879,"answer":"PCR","answer_other":"","report":6210}],"author_username":"Cure Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Other Healthcare Professional","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4243,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6210},{"id":4244,"answer":"Unusual disease presentation","answer_other":"","report":6210}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[{"id":398,"answer":"Black or African American","answer_other":""}],"created":"2020-10-07T18:59:37.265601Z","updated":"2020-11-05T18:02:11.822861Z","title":"Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32371417,"doi":"10.7861/clinmed.2020-0182","article_url":"https://pubmed.ncbi.nlm.nih.gov/32371417/","pub_year":2020,"published_authors":"Wong PF\r\nCraik S\r\nNewman P\r\nMakan A\r\nSrinivasan K\r\nCrawford E\r\nDev D\r\nMoudgil H\r\nAhmad N","article_author_email":"pofung.wong@nhs.net","journal":"Clinical medicine (London, England)","abstract":"A 40 some year-old man developed acute brainstem dysfunction 3 days after hospital admission with symptoms of the novel SARS-CoV-2 infection (COVID-19). Magnetic resonance imaging showed changes in keeping with inflammation of the brainstem and the upper cervical cord, leading to a diagnosis of rhombencephalitis. No other cause explained the patient's abnormal neurological findings. He was managed conservatively with rapid spontaneous improvement in some of his neurological signs and was discharged home with continued neurology follow up.          \r\n        Keywords:      \r\n                  COVID-19; MRI; brainstem encephalitis; hepatitis; rhombencephalitis.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"1","full_text_available":true,"outcome":"Patient improved","surgery":"No","age":"31-40 years","sex":"Male","ethnicity":"Not Hispanic/Latino","country_contracted":"United Kingdom","country_treated":"United Kingdom","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":true,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"Glaucoma","pregnant":false,"unknown":false,"site_of_disease":"Lungs, Brain, Liver","clinical_syndrome":"Pneumonia, Rhombencephalitis, mild bilateral facial weakness, derangement of liver enzymes","severity":"Inpatient","prev_treatment":"","unusual":"A case of rhombencephalitis as a rare complication of acute COVID-19 infection","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"While the patient was still on treatment","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"Patient was previously treated for hypertension with ramipril and amoldipine, and treated for Glaucoma with dorzolamide and timolol maleate eye drops.\r\n\r\nThe patientâ€™s neurological symptoms and liver enzymes improved steadily and he was discharged home after 11 days with neurology follow-up. At discharge he was prescribed gabapentin 300 mg twice per day orally with some resulting improvement in his hiccups and nystagmus but oscillopsia and ataxia persisted.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[5901,9560]}]